Addex Therapeutics (ADXN) Stock Chart & Stock Price History $8.27 +0.00 (+0.05%) As of 07/25/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Addex Therapeutics Stock Price Performance The Addex Therapeutics (ADXN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 3.20%, with a year-to-date return of 17.94%. In the past month, the stock has decreased 6.87%, reflecting recent market activity. As of the latest close, Addex Therapeutics traded at $8.26 with a market cap of $8.75 million and volume of 293 shares. Receive ADXN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Addex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.38%1 Month Performance-6.87%3 Month Performance+6.38%Year-To-Date Performance+17.94%1 Year Performance+3.20% ADXN Stock Chart for Saturday, July, 26, 2025 ADXN Chart by TradingView Addex Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/25/2025$8.28$8.26-0.23%$8.57$8.57293 shs$8.75 million07/24/2025$8.37$8.28-1.14%$8.27$8.27957 shs$8.77 million07/23/2025$8.14$8.37+2.81%$8.61$8.223,386 shs$8.87 million07/22/2025$8.06$8.14+0.95%$8.61$7.524,880 shs$8.63 million07/21/2025$7.54$8.06+6.95%$8.32$8.121,910 shs$8.55 million07/18/2025$8.43$7.54-10.57%$8.71$7.543,218 shs$7.99 million07/17/2025$8.83$8.43-4.52%$8.59$8.50649 shs$8.94 million07/16/2025$9.03$8.83-2.20%$9.00$8.831,980 shs$9.36 million07/15/2025$9.02$9.03+0.06%$9.15$8.832,279 shs$9.57 million07/14/2025$8.89$9.02+1.51%$9.00$9.00448 shs$9.57 million Get the Latest News and Ratings for ADXN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Addex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/11/2025$8.94$8.89-0.56%$9.10$8.835,987 shs$9.42 million07/10/2025$9.29$8.94-3.77%$9.27$8.782,923 shs$9.48 million07/09/2025$9.52$9.29-2.42%$9.44$8.915,294 shs$9.85 million07/08/2025$9.48$9.52+0.42%$9.48$9.05890 shs$10.09 million07/07/2025$9.28$9.48+2.21%$9.48$9.05890 shs$10.05 million07/04/2025$9.28$9.28$9.89$8.9928,993 shs$9.83 million07/03/2025$9.58$9.28-3.13%$9.89$8.9928,993 shs$9.83 million07/02/2025$9.43$9.58+1.59%$9.80$9.0514,874 shs$9.75 million07/01/2025$9.41$9.43+0.16%$9.87$8.9944,098 shs$9.99 million06/30/2025$8.96$9.41+5.02%$9.80$8.8051,904 shs$9.98 million06/27/2025$8.87$8.96+1.07%$9.80$8.5060,692 shs$9.50 million06/26/2025$8.72$8.87+1.72%$9.20$8.549,539 shs$9.40 million06/25/2025$8.68$8.72+0.40%$9.16$9.16292 shs$9.24 million Related Companies Cognition Therapeutics Stock Price Chart KALA BIO Stock Price Chart Biodexa Pharmaceuticals Stock Price Chart Akari Therapeutics Stock Price Chart Telomir Pharmaceuticals Stock Price Chart Coeptis Therapeutics Stock Price Chart Hyperion DeFi Stock Price Chart OnKure Therapeutics Stock Price Chart Mana Capital Acquisition Stock Price Chart Kezar Life Sciences Stock Price Chart Receive ADXN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Addex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ADXN) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addex Therapeutics Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Addex Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.